A preclinical study of A549 cells showed that Cur blocks the migration and invasion of NSCLC by decreasing matrix metalloproteinase (MMP)-2 and 9 and VEGF; p-ERK and MEKK3 signaling pathways are also involved [49]. The gene discussed is VEGFA; the disease is non-small cell lung carcinoma.